Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Construction in Progress (2016 - 2018)

Historic Construction in Progress for Trinity Biotech (TRIB) over the last 3 years, with Q4 2018 value amounting to $204000.0.

  • Trinity Biotech's Construction in Progress fell 6363.64% to $204000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $204000.0, marking a year-over-year decrease of 6363.64%. This contributed to the annual value of $204000.0 for FY2018, which is 6363.64% down from last year.
  • Per Trinity Biotech's latest filing, its Construction in Progress stood at $204000.0 for Q4 2018, which was down 6363.64% from $561000.0 recorded in Q4 2017.
  • In the past 5 years, Trinity Biotech's Construction in Progress registered a high of $778000.0 during Q4 2016, and its lowest value of $204000.0 during Q4 2018.
  • Its 3-year average for Construction in Progress is $514333.3, with a median of $561000.0 in 2017.
  • In the last 5 years, Trinity Biotech's Construction in Progress crashed by 2789.2% in 2017 and then crashed by 6363.64% in 2018.
  • Over the past 3 years, Trinity Biotech's Construction in Progress (Quarter) stood at $778000.0 in 2016, then decreased by 27.89% to $561000.0 in 2017, then plummeted by 63.64% to $204000.0 in 2018.
  • Its last three reported values are $204000.0 in Q4 2018, $561000.0 for Q4 2017, and $778000.0 during Q4 2016.